Thomas Schrader

Title: Thomas Schrader: Innovator in Molecular Therapeutics

Introduction

Thomas Schrader is a notable inventor based in Mettmann, Germany. He has made significant contributions to the field of molecular therapeutics, particularly in the treatment of amyloid-related diseases. With a total of 3 patents, his work focuses on innovative solutions to complex medical challenges.

Latest Patents

One of his latest patents is titled "Molecular tweezers for the treatment of amyloid-related diseases." This invention provides novel compositions designed to inhibit the aggregation of amyloid proteins. In various embodiments, the compositions comprise molecular tweezers that bind lysine and/or arginine, thereby inhibiting the aggregation of amyloidogenic proteins. Another significant patent is related to an "Affinity material," which pertains to an affinity material useful in antibody purification.

Career Highlights

Throughout his career, Thomas Schrader has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His work in these organizations has allowed him to advance his research and contribute to important scientific developments.

Collaborations

Thomas has collaborated with notable colleagues, including Gal Bitan and Sharmistha Sinha. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Thomas Schrader's innovative work in molecular therapeutics highlights his commitment to addressing critical health issues. His patents and collaborations reflect a dedication to advancing medical science and improving patient outcomes.